Written by : Jayati Dubey
February 18, 2025
While Abridge did not disclose its latest valuation, the company was previously valued at $850 million following a $150 million funding round last year.
Abridge, a startup specializing in artificial intelligence-powered medical documentation, has secured $250 million in a funding round co-led by Elad Gil and IVP.
The investment round also saw participation from prominent backers, including Lightspeed Venture Partners, CVS Health Ventures, Redpoint Venture, and NVentures, Nvidia's venture capital arm.
While Abridge did not disclose its latest valuation, the company was previously valued at $850 million following a $150 million funding round last year.
Founded in 2018 and based in Pittsburgh, Abridge uses AI to automate clinical notes and medical conversations, streamlining documentation processes for healthcare providers.
The company's technology is already in use across 100 healthcare systems in the US, including rural hospitals and pediatric care centers.
"AI can be transformative by simplifying the complexities of revenue cycle documentation, allowing clinicians to focus on their patients while ensuring accurate records," said Somesh Dash, General Partner at IVP.
Abridge recently launched Abridge Inside for Emergency Medicine, a generative AI-powered tool designed to optimize documentation in emergency care settings.
The tool is currently deployed at leading health systems, including Deaconess Health System, Emory Healthcare, Johns Hopkins Medicine, and UChicago Medicine.
Developed as part of Abridge's participation in the Epic Workshop program, this innovation integrates with Epic Systems, a major electronic health record (EHR) provider.
With fresh funding, Abridge plans to develop its AI capabilities further and expand its commercial reach, reinforcing its position in the rapidly growing AI-driven healthcare documentation sector.
Stay tuned for more such updates on Digital Health News.